68 related articles for article (PubMed ID: 33053096)
1. Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series.
Giovanella L; Milan L; Roll W; Weber M; Schenke S; Kreissl M; Vrachimis A; Pabst K; Murat T; Petranović Ovčariček P; Campenni A; Görges R; Ceriani L
Clin Chem Lab Med; 2024 May; ():. PubMed ID: 38706105
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer.
Szujo S; Bajnok L; Bodis B; Nagy Z; Nemes O; Rucz K; Mezosi E
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467717
[TBL] [Abstract][Full Text] [Related]
3. Value of thyroglobulin post hemithyroidectomy for cancer: a literature review.
Tourani SS; Fleming B; Gundara J
ANZ J Surg; 2021 Apr; 91(4):724-729. PubMed ID: 33244886
[TBL] [Abstract][Full Text] [Related]
4. Current practice in patients with differentiated thyroid cancer.
Schlumberger M; Leboulleux S
Nat Rev Endocrinol; 2021 Mar; 17(3):176-188. PubMed ID: 33339988
[TBL] [Abstract][Full Text] [Related]
5. Radioactive iodine treatment of papillary thyroid carcinoma in Japan.
Okamoto T; Omi Y; Yoshida Y; Horiuchi K; Abe K
Gland Surg; 2020 Oct; 9(5):1698-1707. PubMed ID: 33224847
[TBL] [Abstract][Full Text] [Related]
6. Newborn Screening for Congenital Hypothyroidism: the Benefit of Using Differential TSH Cutoffs in a 2-Screen Program.
Caiulo S; Corbetta C; Di Frenna M; Medda E; De Angelis S; Rotondi D; Vincenzi G; de Filippis T; Patricelli MG; Persani L; Barera G; Weber G; Olivieri A; Vigone MC
J Clin Endocrinol Metab; 2021 Jan; 106(1):e338-e349. PubMed ID: 33124651
[TBL] [Abstract][Full Text] [Related]
7. Unstimulated Serum Thyroglobulin Levels after Thyroidectomy and Radioiodine Therapy for Intermediate-Risk Thyroid Cancer Are Not Always a Reliable Marker of Lymph Node Recurrence: Case Report and a Lesson for Clinicians.
Foppiani L; Sola S; Cabria M; Bottoni G; Piccardo A
Case Rep Endocrinol; 2020; 2020():8827503. PubMed ID: 33101736
[TBL] [Abstract][Full Text] [Related]
8. Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma.
Signore A; Lauri C; Di Paolo A; Stati V; Santolamazza G; Capriotti G; Prosperi D; Tofani A; Valabrega S; Campagna G
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296937
[TBL] [Abstract][Full Text] [Related]
9. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract][Full Text] [Related]
10. Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer.
Paudel J
World J Nucl Med; 2023 Sep; 22(3):208-216. PubMed ID: 37854090
[No Abstract] [Full Text] [Related]
11. Thyroglobulin as a Rapid and Cost-Effective Biomarker for Diagnosis of Thyroid Carcinoma Brain Metastasis: A Case Report of a Patient with Metastatic Hurthle Cell Thyroid Carcinoma.
Ntotsikas K; Lazarioti S; Daraki V; Drakos E; Tsakalomatis PN; Syntzanaki EK; Moustakis N; Marinis AI; Salapatas-Gkinis A; Xekouki P; Vakis A; Tsitsipanis C
Am J Case Rep; 2023 Oct; 24():e939025. PubMed ID: 37853680
[TBL] [Abstract][Full Text] [Related]
12. Metastatic differentiated thyroid cancer: worst prognosis in patients with metachronous metastases.
González-Clavijo AM; Cuellar AA; Triana-Urrego J; Barrero JA; Fierro-Maya LF
Endocrine; 2023 Jul; 81(1):90-97. PubMed ID: 37171525
[TBL] [Abstract][Full Text] [Related]
13. The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.
Li S; Ren C; Gong Y; Ye F; Tang Y; Xu J; Guo C; Huang J
Front Endocrinol (Lausanne); 2022; 13():872527. PubMed ID: 35721746
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of potential novel biomarkers to predict distant metastasis in differentiated thyroid cancer.
Wang W; Shen C; Zhao Y; Sun B; Bai N; Li X
Ann Transl Med; 2021 Jul; 9(13):1053. PubMed ID: 34422965
[TBL] [Abstract][Full Text] [Related]
15. A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients.
Couto JS; Almeida MFO; Trindade VCG; Marone MMS; Scalissi NM; Cury AN; Ferraz C; Padovani RP
Braz J Med Biol Res; 2020; 53(11):e9781. PubMed ID: 33053096
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
17. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
18. The Value of Stimulated Thyroglobulin Before the First Radioactive Iodine Treatment in Metastasis for Differentiated Thyroid Carcinoma.
Ren L; Zhang C; Shen Y; Mo A; Hu Y; Sun J; Yuan C; Wen W
Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107643
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
